IP Library Granted Patent US 12,414,720
Granted Patent B2
US 12,414,720 · App. 17/744,217 · Granted Sep 16, 2025

Implantable medical devices, systems and methods for reducing T-wave oversensing and arrhythmia undersensing

Inventors: Yun Qiao (Sunnyvale, CA); Nima Badie (Oakland, CA); Wenwen Li (Studio City, CA); Chaoyi Kang (Northridge, CA); Jan Mangual (Milan, IT); Fady Dawoud (Studio City, CA)
Assignee: Pacesetter, Inc.
A61B5/29A61B5/33A61B5/335A61B5/352A61B5/355A61B5/361A61B5/363
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,720
App. No.
17/744,217
Granted
Sep 16, 2025
Kind
B2
Abstract

Described herein are implantable medical devices and systems, and methods for use therewith, for reducing T-wave oversensing and arrhythmia undersensing that occur due to inappropriate filtering of a signal indicative of cardiac electrical activity. A method includes obtaining a signal indicative of cardiac electrical activity, and using a first bandpass filter to produce a first filtered version thereof, using a second bandpass filter to produce a second filtered version thereof, wherein the first bandpass filter passes frequencies within a first frequency range, and the second bandpass filter passes frequencies within a second frequency range that is wider than the first frequency range. The method also includes selectively changing from using the first filtered version of the signal to monitor for a VS event, to using the second filtered version of the signal to monitor for a VS event, based on first criteria, and vice versa, based on second criteria.

Claims (54)

1. An apparatus, comprising:

two or more electrodes;

a sensing circuit coupleable to at least two of the electrodes to thereby sense a signal indicative of cardiac electrical activity;

a first bandpass filter configured to pass frequencies within a first frequency range and that can be used to produce a first filtered version of the signal indicative of cardiac electrical activity;

a second bandpass filter configured to pass frequencies within a second frequency range and that can be used to produce a second filtered version of the signal indicative of cardiac electrical activity, wherein the second frequency range is wider than the first frequency range;

an R-wave detector; and

a controller configured to cause only one of the first or second filtered versions of the signal indicative of cardiac electrical activity to be provided to the R-wave detector at a time;

the R-wave detector configured to monitor for a potential ventricular sensed (VS) event based on the only one of the first or second filtered versions of the signal indicative of cardiac electrical activity, which is caused to be provided to the R-wave detector by the controller at the time; and

the controller configured to

determine whether one or more first criteria are satisfied, in response to a said potential VS event being detected by the R-wave detector based on the first filtered version of the signal indicative of cardiac electrical activity; and

change from causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the determination of whether the one or more first criteria are satisfied.

2. The apparatus of claim 1 , wherein:

the first frequency range passed by the first bandpass filter is one of 6-25 Hz or 8-25 Hz; and

the second frequency range passed by the second bandpass filter is 3-25 Hz.

3. The apparatus of claim 1 , wherein the controller is configured to:

determine whether one or more second criteria are satisfied, in response to a said potential VS event being detected by the R-wave detector based on the second filtered version of the signal indicative of cardiac electrical activity; and

change from causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the determination of whether the one or more second criteria are satisfied.

4. The apparatus of claim 3 , wherein the one or more first criteria are configured to at least one of:

detect R-wave undersensing; and

reduce a chance of R-wave undersensing during an episode of at least one of ventricular tachycardiac (VT) or ventricular fibrillation (VF).

5. The apparatus of claim 3 , wherein the one or more first criteria include:

(i) a prevalence of T-wave oversensing is below a first specified prevalence threshold, and a specified amount of most recently detected potential VS events each have a peak amplitude below a first specified amplitude threshold;

(ii) a duration of time between the detected potential VS event and an immediately preceding detected potential VS event exceeds a first specified duration threshold; and

(iii) a duration of time between the detected potential VS event and an immediately preceding detected potential VS event exceeds a second specified duration threshold, which is less than the first specified duration threshold, and a peak amplitude of the detected potential VS event is below a second specified amplitude threshold; and

wherein the controller changes from causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, in response to the controller determining that at least one of the criteria (i), (ii), or (iii) is true.

6. The apparatus of claim 4 , wherein the one or more first criteria includes:

(iv) at least one of ventricular tachycardiac (VT) or ventricular fibrillation (VF) is (iv) currently being detected; and

wherein the controller changes from causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, in response to the controller determining that the criterion (iv) is true.

7. The apparatus of claim 3 , wherein the one or more second criteria are used by the controller to reduce a chance of T-wave oversensing causing a false detection of ventricular tachycardiac (VT) or ventricular fibrillation (VF).

8. The apparatus of claim 1 , wherein;

the first and second filtered versions of the signal indicative of cardiac electrical activity are produced in parallel by passing the signal indicative of cardiac electrical activity through the first bandpass filter included within a first channel, and also separately passing the signal indicative of cardiac electrical activity through the second bandpass filter included in a second channel; and

the controller controls whether the first channel or the second channel is coupled to the R-wave detector.

9. The apparatus of claim 1 , wherein:

the controller is configured to make an additional determination whether the one or more first criteria are satisfied each time the R-wave detector detects an additional potential VS event based on the first filtered version of the signal indicative of cardiac electrical activity, and to change from causing the first filtered version of the signal indicative of cardiac electrical activity to causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the additional determination of whether the one or more first criteria are satisfied.

10. The apparatus of claim 3 , wherein:

the controller is configured to make an additional determination whether the one or more first criteria are satisfied each time the R-wave detector detects an additional potential VS event based on the first filtered version of the signal indicative of cardiac electrical activity, and to change from causing the first filtered version of the signal indicative of cardiac electrical activity to causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the additional determination of whether the one or more first criteria are satisfied; and

the controller is configured to make an additional determination whether the one or more second criteria are satisfied each time the R-wave detector detects an additional potential VS event based on the second filtered version of the signal indicative of cardiac electrical activity, and to change from causing the second filtered version of the signal indicative of cardiac electrical activity to causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the additional determination of whether the one or more second criteria are satisfied.

11. An apparatus, comprising:

two or more electrodes;

a sensing circuit coupleable to at least two of the electrodes to thereby sense a signal indicative of cardiac electrical activity;

a first bandpass filter configured to pass frequencies within a first frequency range and that can be used to produce a first filtered version of the signal indicative of cardiac electrical activity;

a second bandpass filter configured to pass frequencies within a second frequency range and that can be used to produce a second filtered version of the signal indicative of cardiac electrical activity, wherein the second frequency range is wider than the first frequency range;

an R-wave detector; and

a controller configured to cause only one of the first or second filtered versions of the signal indicative of cardiac electrical activity to be provided to the R-wave detector at a time;

the R-wave detector configured to monitor for a potential ventricular sensed (VS) event based on the only one of the first or second filtered versions of the signal indicative of cardiac electrical activity, which is caused to be provided to the R-wave detector by the controller at the time; and

the controller configured to

determine whether one or more first criteria are satisfied, in response to a said potential VS event being detected by the R-wave detector based on the first filtered version of the signal indicative of cardiac electrical activity; and

change from causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the determination of whether the one or more first criteria are satisfied;

determine whether one or more second criteria are satisfied, in response to a said potential VS event being detected by the R-wave detector based on the second filtered version of the signal indicative of cardiac electrical activity; and

change from causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, based on results of the determination of whether the one or more second criteria are satisfied;

wherein the one or more second criteria include:

(i) neither ventricular tachycardiac (VT) nor ventricular fibrillation (VF) is currently being detected; and

(ii) a specified amount of most recently detected potential VS events each have a peak amplitude above a further specified amplitude threshold, or have been classified as having been detected due to T-wave oversensing; and

wherein the controller changes from causing the second filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, to causing the first filtered version of the signal indicative of cardiac electrical activity to be provided to the R-wave detector, in response to the controller determining that both criteria (i) and (ii) are true.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2022
From: QIAO, YUN; BADIE, NIMA; LI, WENWEN; KANG, CHAOYI; MANGUAL, JAN; DAWOUD, FADY
To: PACESETTER, INC.
Reel/Frame 059906/0668 →
Continuity (2)
Provisional Application 63262778 · Oct 20, 2021
Related Publication 20230121674A1 · Apr 20, 2023
References Cited (31)
US 6671548B1 · Mouchawar et al. · 2003 [cited by applicant]
US 8914106B2 · Charlton et al. · 2014 [cited by applicant]
US 9597525B2 · Cao et al. · 2017 [cited by applicant]
US 10149627B2 · Allavatam · 2018 [cited by examiner]
US 10328274B2 · Zhang et al. · 2019 [cited by applicant]
US 10888238B2 · Allavatam et al. · 2021 [cited by applicant]
US 20030204215A1 · Gunderson et al. · 2003 [cited by applicant]
US 20040199082A1 · Ostroff et al. · 2004 [cited by applicant]
US 20070032829A1 · Ostroff · 2007 [cited by applicant]
US 20080103535A1 · Ostroff et al. · 2008 [cited by applicant]
US 20090018595A1 · Bharmi · 2009 [cited by examiner]
US 20100280567A1 · Gunderson · 2010 [cited by applicant]
US 20160325106A1 · Cao et al. · 2016 [cited by applicant]
US 20170050037A1 · Hahn et al. · 2017 [cited by applicant]
US 20170156617A1 · Allavatam et al. · 2017 [cited by applicant]
US 20180064360A1 · Siejko · 2018 [cited by examiner]
US 20180318588A1 · Dennis · 2018 [cited by applicant]
US 20190329038A1 · Rhude · 2019 [cited by applicant]
US 20190350481A1 · Sarkar · 2019 [cited by examiner]
US 20190365267A1 · Aranda Hernandez · 2019 [cited by examiner]
US 20210282717A1 · Loring et al. · 2021 [cited by applicant]
EP 3209376A1 · 2017 [cited by applicant]
EP 3383486A1 · 2018 [cited by applicant]
“Spontaneous T-wave oversensing,” Cardiocases, Pacing & Defibrillation, ICT in 20 clinical situations, downloaded on Apr. 22, 2022, [https://www.cardiocases.com/en/pacingdefibrillation/clinical-situation/icd/spontaneous… [cited by applicant]
International Search Report & The Written Opinion of the International Searching Authority dated Oct. 12, 2022, International Application No. PCT/US2022/038392. [cited by applicant]
Boston Scientific, “The Impact of Smart Pass on Reducing Inappropriate Shocks for S-ICD,” Boston Scientific Corporation, CRM-712201-AB, May 2020, 2 pages. [cited by applicant]
Boston Scientific, “The Evolution of S-ICD Technology,” downloaded on Oct. 5, 2023, [—https://www.bostonscientific.com/en-US/products/defibrillators/emblem-s-icd-system/device-overview/specifications.html#:˜:text=8.7%20… [cited by applicant]
Boston Scientific, “User's Manual—Subcutaneous Implantable Cardioverter Defibrillator,” Boston Scientific Corporation, Jan. 2017, 72 pages. [cited by applicant]
International Preliminary Report on Patentability dated May 2, 2024, International Application No. PCT/US2022/038392. [cited by applicant]
Communication pursuant to Rules 161(1) and 162 EPC dated May 28, 2024, European Patent Application No. 22754692.6-1113. [cited by applicant]
Response to Communication pursuant to Rules 161(1) and 162 EPC dated Jul. 10, 2024, European Patent Application No. 22754692.6-1113. [cited by applicant]